corlife
General Information
Identification Code: 169673727443-86
Website: [object Object]
Entity Form: oHG
Registration Category: Companies & groups
Registration Date: 6/9/2017
Last Update: 2/8/2024
EP Accredited Number: 0
Mission & Interests
Goals: Corlife entwickelt und produziert am Firmensitz in Hannover innovative Produkte für die Herzchirurgie. Das Hauptaugenmerk liegt dabei auf zellfreien, regenerativen Gewebeimplantaten, die vor allem bei der Korrektur angeborener Herzfehler angewendet werden.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
- Research and innovation
Levels of Interest:
- european
Activities
Main EU Legislative Proposals: Stakeholder consultation for the evaluation of eu legislation on blood, tissues and cells. Participation in the Commissions public consultation on a new regulation on standards of quality and safety for substances of human origin intended for human application (Soho). corlife gave feedback to the commissions adoption under the umbrella of the organisation BPI on 31.08.2022.
Communication Activities: On 10.10.2023 the BPI had a meeting with EU parlamentarians ( Lena Düpont / EVP, CDU and Rasmus Andresen / Freie Europäische Allianz, Grüne) in Brussels concerning the SoHo regulation. For this meeting also corlife was invited and had been able to discuss about this topic with the parlamentarians.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Feodor-Lynen-Str. 23
Post Code: 30625
City: Hannover
Country: GERMANY
Phone: [object Object]
EU Office
Address: Feodor-Lynen-Str. 23
Post Code: 30625
City: Hannover
Country: GERMANY
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.25
Structure
Structure Type: Structure
Is Member Of: n.a.
Organisation Members: The German Pharmaceutical Industry Association (BPI) represents the interests of around 260 pharmaceutical and biotech companies in Germany with approximately 70,000 employees: start-ups, SMEs and multinational companies. www.bpi.de
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent. BPI is member of the EUCOPE (www.eucope.org)